BOIRON 2015 HALF-YEAR ACTIVITY
(Unaudited data)
July 17, 2015
CUMULATIVE ACTIVITY AS OF THE END OF JUNE 2015
thousands of euros
2014 2015 Variation at current exchange rates
Variation at constant exchange rates
France 157,018 166,448 + 6.0% + 6.0% Europe (excluding France) 73,537 70,600 - 4.0% - 2.6% North America 23,287 30,087 + 29.2% + 7.7% Other countries 7,774 8,438 + 8.5% + 9.7%
Group total 261,616 275,573 + 5.3% + 3.9%
thousands of euros
2014 2015 Variation at current exchange rates
Variation at constant exchange rates
Non-proprietary Homeopathic Medicines 150,991 153,545 + 1.7% + 0.7% OTC Specialties 110,254 121,910 + 10.6% + 8.4% Other 371 118 - 68.2% - 43.9% Group total 261,616 275,573 + 5.3% + 3.9%
ACTIVITY IN THE QUARTER(variation at current rate)
1stQuarter 2ndQuarter
thousands of euros 2014 2015 Var.
15/14
2014 2015 Var.
15/14
France 82,749 89,584 +8.3% 74,269 76,864 +3.5% Europe (excluding France) 39,967 40,657 +1.7% 33,570 29,943 -10.8% North America 12,662 17,193 +35.8% 10,625 12,894 +21.4% Other countries 4,831 4,622 -4.3% 2,943 3,816 +29.7%
Group total 140,209 152,056 +8.4% 121,407 123,517 +1.7%
1stQuarter 2ndQuarter
thousands of euros 2014 2015 Var.
15/14
2014 2015 Var.
15/14
Non-proprietary Homeopathic Medicines 77,919 79,191 +1.6% 73,072 74,354 +1.8% OTC Specialties 62,196 72,880 +17.2% 48,058 49,030 +2.0% Other 94 -15 - 277 133 -52.0%
Group total 140,209 152,056 +8.4% 121,407 123,517 +1.7%
HIGHLIGHTS OF THE SECOND QUARTER 2015
Sales in the second quarter of 2015 rose by 1.7% compared to the second quarter of 2014: business activity increased in France and the US and decreased, especially, in Russia, Spain and Poland.
Profitability in the first half of 2015 should rise compared to 2014.
BOIRON will continue its involvement in the development of homeopathy with confidence and ambition. Taking into account the geopolitical risks, especially in Russia, the BOIRON group remains cautious in its outlook for 2015.
Our next update:
September 3, 2015: at market close, publication of 2015 half-year results. Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA The group's financial information is online at: www.boironfinance.com
|
distributed by
|
